| Information | |
|---|---|
| Name of lifestyle | Benign prostatic hypertrophy medication |
| Third Class | Benign prostatic hypertrophy(BPH) medication |
| Second Class | Drug |
| First Class | Clinical characteristics |
| Unit | NA |
| Stratification |
25824539:No or concurrent BPHhistory
and unexposed to
BPH-m;BPH-history positive unexposed
to BPH-medication;BPH-history positive and 5α-
reductase inhibitor e;BPH-history positive and
α-blocker exposure;BPH-history positive and other
BPH-medication expo |
| Type of influence factor |
Protective factor Risk factor No statistical significance factor |
| Classification of Lifestyles |
Clinical characteristics |
| The affected types of PCa |
Total PCa Low grade PCa |
| Number of studies involved | 1 |
| 1 Items, 1 Pages <<Prev 1 Next>> All | |||||||
|---|---|---|---|---|---|---|---|
| Research involved | |||||||
| PMID | First auther | Year | Area | Duration | Study type | Sample size | More |
| 25824539 | Katharina Boehm | 2015 | Canada (Montreal) | 2005, 2012 | case–control | 1834;1956 | outcome |